Alternatively, inhibition of TNFα activity using anti-inflammatory drugs improved liver damage, inflammation, and NASH (Li et al., 2003; Koppe et al., 2004). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.